| Prev Close | 218.15 |
| Day Low/High | 216.03 / 219.03 |
| 52 Wk Low/High | 104.28 / 242.62 |
Constellation Brands, Inc. Class A (STZ)
216.06
NYSE
| Exchange | NYSE |
| Shares Outstanding | 193.91B |
| Market Cap | 42.30B |
| P/E Ratio | 21.86 |
| Div & Yield | N.A. (N.A) |
Here's Why Tilray Stock Is the Wild Child
Perhaps the highest profile impact on Tilray equity performance has been the interest of Andrew Left of Citron Research.
Tilray Stock Higher Ahead of First Post-Legalization Earnings Release
Tilray will have a lot to tackle this evening.
Focus on FOMC After Rip-Roaring Day for Stocks: Market Recon
Consumer Discretionary stocks were the hottest on Wednesday, though all eleven sectors easily finished in the green.
What Barclays Gets Wrong About Cannabis and Tobacco
Cannabis and tobacco are hard to equate, which Barclays' primer on the Cannabis industry misses.
Constellation Brands Shows a Curious Mix of Charts and Indicators
Constellation Brands is the kind of company that typically does well in a weak market environment.
CGC Is the One Must-Own Cannabis Stock
Canopy Growth already has a $4 billion war chest thanks to Constellation Brands.
Check Out These Stocks as Canada Is About to Be Smokin' Hot
On Wednesday, Canada becomes the first major economy to legalize the recreational use of cannabis.
Jim Cramer: Wednesday Is a Watershed Day for Cannabis Stocks
But don't buy into this overheated market right as Canada legalizes, wait until prices come down -- which they will.
Canopy Growth Is Poised to Explode to the Upside
Let's look at the charts and technical indicators.
Jim Cramer: I'm Not Saying the Fed's Gone Crazy, I'm Saying It's Gone Lazy
The Fed's crystal ball is very clouded.
Play a Potential Altria Pivot Into Pot
The time to scoop up Altria is now, not when some type of official announcement is made.
Canopy Growth and 4 Other Cannabis Stocks That Look Good Here
These stocks offer some diversification or unique features in the legal-weed space.
Chart of the Day: Constellation's Canopy Growth Engine
Canopy Growth could be Constellation's next big growth engine.
Constellation Shares Soar on Thursday
Shareholders enjoyed a crisp day of gains after Constellation cracked open a great earnings report pre-market.
Constellation Shareholders Cautious About the Company's Big Debt Burden
Investors and experts need more time before they go all in on cannabis.
Analysts, Traders Bullish on Constellation as it Shatters Earnings Estimates
Market experts are abuzz over Constellation's potential new inroads into the cannabis market.
Down the Marijuana Rabbit Hole: 5 Companies to Consider
It's too easy to lump all cannabis-related stocks into the moniker "marijuana." Like many other sectors, there are differentiators underneath the same way we see in semiconductors or retail or even energy. As you go down the marijuana rabbit hole, ...
Constellation Brands Is a Bright Star on a Down Day
With STZ's earnings beat and the potential of the CGC investment, investors are willing to pay a premium.
Want to Buy Constellation Brands Stock Today? Read On
I have no problem blessing an investment in this name with the appropriate steps taken toward risk management.
Constellation Brands Surges Higher, Start of a New Uptrend
A strong upside gap this morning really changes the picture.
Constellation Brands Buzzes on Raised Guidance, Growth Engines
Constellation looks to wine, beer, and cannabis to take it higher.
7 Smart Ways to Invest in Cannabis Stocks and Not Get Burned
There are several avenues to invest in the potential cannabis boom -- recreational plays; medical plays; and companies that have a lot to gain from the industry but aren't reliant upon it for success.
Two Cheers for Corona and Cannabis: Constellation Jumps on Earnings
Constellation looks like a star today after beating expectations.
2 Plays on JP Morgan to Boost Bank Exposure: Market Recon
Try these trades in JPM and Key to take advantage of weakness in the sector.
Cannabis Shorts: Is There Enough Liquidity?
Before you short cannabis names, read this.
Cannabis Could Disrupt the Lucrative Market for Painkillers
Painkiller manufacturers might see their profits hurt by medical cannabis in the near future.
Canopy Growth CEO: Traditional Firms Will See They Must Get Into Legal Cannabis
The only other option is 'to fearfully wait' for the legal-weed industry to expand.
Despite Taking Some Weed, Constellation Brands Charts Are Still Bearish
It is entirely possible that a business relationship with Canopy Growth will help Constellation Brands, but the charts currently suggest further risk for the beverage company.
Jim Cramer: Reefer Madness
Tilray's a disruptive company for many industries.
If You Must Trade Tilray, Use This Options Play: Market Recon
Covered calls may be the best bet -- or wait for a dip.
